Researchers from The Cancer Genome Atlas Network recently published two studies—one identifying seven distinct molecular subtypes of prostate cancer, and one exploring the genetic drivers of papillary renal cell carcinoma.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
